UPDATE : Monday, March 18, 2019
EzCareTech to speed up global presence with IPO by Lee Han-soo 2019-03-06 14:58
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate by Lee Han-soo 2019-03-06 14:27
Binex, Chongqing Zein to establish joint company by Lee Han-soo 2019-03-06 13:41
Europe OKs Samsung Bioepis’ biosimilar treatment of breast cancer by Lee Han-soo 2019-03-05 17:53
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin by Lee Han-soo 2019-03-05 16:22
Hanmi’s acute myeloid leukemia wins developmental stage orphan drug status by Lee Han-soo 2019-03-05 15:34
Handok to market Amicus Therapeutics’ Fabry disease treatment by Lee Han-soo 2019-03-05 15:11
IVI gets $3.2 million for typhoid conjugate vaccine study in W. Africa by Lee Han-soo 2019-03-05 14:41
World’s 5th gastrointestinal endoscopy conference to kick off in Korea by By Kim Yun-mi 2019-03-04 18:08
Hanmi releases P4 clinical trials for anti-hypertension treatment by Lee Han-soo 2019-03-04 17:01
AbbVie gets positive views for treatment of plaque psoriasis in EU by Lee Han-soo 2019-03-04 15:57
Roche Diagnostic Korea names new general manager by Lee Han-soo 2019-03-04 14:16
Qurient unveils P2a trial results for atopic dermatitis treatment in US by Lee Han-soo 2019-03-04 14:16
US trade agency begins probe into Medytox’s complaint about Daewoong by Lee Han-soo 2019-03-04 11:16
Bridge Biotherapeutics to accelerate global presence by Lee Han-soo 2019-03-04 10:50
Doctors, medical students struggled for Korea’s independence from Japanese colonialists by Lee Han-soo 2019-03-01 07:36
GC starts P1 trials of hemophilia treatment by Lee Han-soo 2019-02-28 16:45
Bukwang to sell Novartis’ chronic hepatitis B treatment by Lee Han-soo 2019-02-28 14:59
Korea to host annual Congress of Asian Society of Head and Neck Oncology by Lee Han-soo 2019-02-27 14:09
National Cancer Center finds mechanism of cancer progression in osteosarcoma by Lee Han-soo 2019-02-27 11:09
Back to Top